Ocular Therapeutix (OCUL) Inventory Average (2014 - 2026)

Ocular Therapeutix's Inventory Average history runs 13 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 15.72% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 15.72% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 23.55% from the prior year.
• Inventory Average grew to $3.7 million in Q1 2026 per OCUL's latest filing, from $3.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $3.7 million in Q1 2026 and bottomed at $1.3 million in Q1 2022.
• The 5-year median for Inventory Average is $2.4 million (2024), against an average of $2.5 million.
• Across the five-year window, Inventory Average jumped 62.58% in 2023 and rose 11.01% in 2024, its largest moves.
• Year by year, Inventory Average stood at $1.8 million in 2022, then climbed by 29.64% to $2.3 million in 2023, then grew by 19.36% to $2.7 million in 2024, then advanced by 29.51% to $3.5 million in 2025, then climbed by 3.53% to $3.7 million in 2026.
• Per Business Quant, the three latest OCUL Inventory Average figures stand at $3.7 million (Q1 2026), $3.5 million (Q4 2025), and $3.3 million (Q3 2025).